|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00588510 |
|
Date of registration:
|
24/12/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
|
|
Scientific title:
|
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction |
|
Date of first enrolment:
|
January 2000 |
|
Target sample size:
|
59 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00588510 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Paul Meyers, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Memorial Sloan-Kettering Cancer Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with osteosarcoma are the study group
- Patients with malignant diagnoses other than osteosarcoma, neuroblastoma, Ewing's
sarcoma or synovial sarcoma may participate as controls
- Histologically proven osteosarcoma or a history of histologically proven osteosarcoma
are eligible for participation. The patient does not need to be newly diagnosed for
enrollment on this protocol
- Patients with malignant diagnosis other than osteosarcoma, neuroblastoma, Ewing's
sarcoma or synovial sarcoma are eligible to participate if they have a central venous
catheter and routine blood work is being drawn
Exclusion Criteria:
- Patients less then three years of age
- Patients with Ewing's sarcoma, neuroblastoma and synovial sarcoma will be excluded
from this protocol
Age minimum:
3 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Osteosarcoma
|
|
Intervention(s)
|
|
Other: Blood draw
|
|
Primary Outcome(s)
|
|
To determine if circulating osteosarcoma cells can be reliably detected and quantitated in the blood of patients with localized and advanced osteosarcoma.
[Time Frame: conclusion of the study]
|
|
Secondary Outcome(s)
|
|
To determine if the presence of circulating osteosarcoma tumor cells is associated with patient outcome.
[Time Frame: conclusion of the study]
|
|
To determine the frequency circulating osteosarcoma cells can be detected in the blood of patients at diagnosis, during therapy, at the completion of all planned therapy and at relapse.
[Time Frame: conclusion of the study]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|